DESCRIPTION: Infection rate following CIED device implantation, replacement, or revision

Similar documents
DESCRIPTION: Infection rate following CIED device implantation, replacement, or revision

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care

2016 ST. JUDE MEDICAL THERAPY CODING GUIDE Cardiac Pacemakers

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care

Quality ID #457 (NQF 0216): Proportion Admitted to Hospice for less than 3 days- National Quality Strategy Domain: Effective Clinical Care

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2017 Procedural Payment Guide Hospital Inpatient, Hospital Outpatient, ASC and Physician Reimbursement Information

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

Quality ID #342: Pain Brought Under Control Within 48 Hours National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Quality ID #413: Door to Puncture Time for Endovascular Stroke Treatment National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: Patients aged 18 and older with infrarenal non-ruptured endovascular AAA repairs

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Procedural Payment Guide

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Measure #409: Clinical Outcome Post Endovascular Stroke Treatment National Quality Strategy Domain: Effective Clincial Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Quality ID #1 (NQF 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) National Quality Strategy Domain: Effective Clinical Care

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

DENOMINATOR: Patients undergoing endovascular lower extremity revascularization

Measure #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Supplemental Material

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

Quality ID #414: Evaluation or Interview for Risk of Opioid Misuse National Quality Strategy Domain: Effective Clinical Care

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Efficiency High Priority

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

Measure #340 (NQF 2079): HIV Medical Visit Frequency - National Quality Strategy Domain: Efficiency And Cost Reduction

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Quality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #443: Non-Recommended Cervical Cancer Screening in Adolescent Females National Quality Strategy Domain: Patient Safety

Measure #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clincal Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Measure #408: Opioid Therapy Follow-up Evaluation National Quality Strategy Domain: Effective Clinical Care

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

DESCRIPTION: The percentage of adolescent females years of age who were screened unnecessarily for cervical cancer

Quality ID #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Sample page. DRG Desk Reference. The ultimate resource for improving MS-DRG assignment practices DESK REFERENCE

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Quality ID #291: Parkinson s Disease: Cognitive Impairment or Dysfunction Assessment National Quality Strategy Domain: Effective Clinical Care

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #357: Surgical Site Infection (SSI) National Quality Strategy Domain: Effective Clinical Care

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

COMMONLY BILLED CODES AND ASSOCIATED 2018 MEDICARE RATES

Quality ID #351: Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation National Quality Strategy Domain: Patient Safety

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #435: Quality of Life Assessment For Patients With Primary Headache Disorders National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

Transcription:

Measure #393: HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION: Infection rate following CIED device implantation, replacement, or revision INSTRUCTIONS: This measure is to be reported a minimum of once per performance period for patients with a CIED device implantation, replacement, or revision performed from January 1, 2017 through June 30, 2017 of the performance period. This measure may be reported by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. NOTE: Include only patients that have had CIED implantation, replacement, or revision performed by June 30. This timeframe allows for evaluation of infection requiring within 180 days within the performance period. This will allow the evaluation of infection status post CIED implantation, replacement, or revision within the reporting year. Infection rates for new implants shall be calculated and reported separately from device replacements and revisions. Additional reporting stratification categories may be useful; however, these stratifications are not required for purposes of QPP reporting: Device class (e.g., pacemaker, ICD) and type (e.g., single chamber, dual chamber); Advanced renal disease (CKD stages 4 and 5, ESRD); Diabetes; CIED infection requiring device removal within 180 days prior to index CIED procedures; and CIED-related surgical procedure within 180 days prior to current CIED procedure. Measure Reporting: The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data. THERE ARE TWO REPORTING CRITERIA FOR THIS MEASURE: 1. Patients, regardless of age, with a new CIED OR 2. Patients, regardless of age, with a replaced or revised CIED REPORTING CRITERIA 1: PATIENTS WITH A NEW CIED DENOMINATOR (REPORTING CRITERIA 1): All patients with a new CIED from January 1, 2017 through June 30, 2017 of the reporting period Definition: CIEDs encompassed for this measure are the following devices: Pacemaker devices (single or dual chamber); 1 of 11

Implantable cardioverter-defibrillators (ICDs, single or dual chamber); Cardiac resynchronization devices (pacemaker or ICD); and Implantable loop recorders (ILRs) Denominator Criteria (Eligible Cases) 1: All patients, regardless of age AND Codes for CIED implantation, replacement, or revision (ICD-10-CM, ICD-10-PCS procedure codes): 02H40JZ, 02H40KZ, 02H40MZ, 02H43JZ, 02H43KZ, 02H43MZ, 02H44JZ, 02H44KZ, 02H44MZ, 02H60JZ, 02H60KZ, 02H60MZ, 02H63JZ, 02H63KZ, 02H63MZ, 02H64JZ, 02H64KZ, 02H64MZ, 02H70JZ, 02H70KZ, 02H70MZ, 02H73JZ, 02H73KZ, 02H73MZ, 02H74JZ, 02H74KZ, 02H74MZ, 02HK0JZ, 02HK0KZ, 02HK0MZ, 02HK3JZ, 02HK3KZ, 02HK3MZ, 02HK4JZ, 02HK4KZ, 02HK4MZ, 02HL0JZ, 02HL0KZ, 02HL0MZ, 02HL3JZ, 02HL3KZ, 02HL3MZ, 02HL4JZ, 02HL4KZ, 02HL4MZ, 02HN0JZ, 02HN0KZ, 02HN0MZ, 02HN3JZ, 02HN3KZ, 02HN3MZ, 02HN4JZ, 02HN4KZ, 02HN4MZ, 02PA0MZ, 02PA3MZ, 02PA4MZ, 02PAXMZ, 02WA0MZ, 02WA3MZ, 02WA4MZ, 0JH604Z, 0JH605Z, 0JH606Z, 0JH607Z, 0JH608Z, 0JH609Z, 0JH60PZ, 0JH634Z, 0JH635Z, 0JH636Z, 0JH637Z, 0JH638Z, 0JH639Z, 0JH63PZ, 0JH804Z, 0JH805Z, 0JH806Z, 0JH807Z, 0JH808Z, 0JH809Z, 0JH80PZ, 0JH834Z, 0JH835Z, 0JH836Z, 0JH837Z, 0JH838Z, 0JH839Z, 0JH83PZ, 0JPT0PZ, 0JPT3PZ, 0JWT0PZ, 0JWT3PZ, R50.81, R50.9 AND/OR Patient encounter during performance period (CPT): 33202, 33203, 33206, 33207, 33208, 33212, 33213, 33214, 33215, 33216, 33217, 33218, 33220, 33221, 33222, 33223, 33224, 33225, 33226, 33227, 33228, 33229, 33240, 33249, 33262, 33263, 33264, 33270, 33271, 33272, 33273, 33282, 93260, 93261 AND New CIED AND NOT DENOMINATOR EXCLUSION: Patients undergoing heart transplantation (ICD-10-PCS procedure codes): 02YA0Z2 NUMERATOR (REPORTING CRITERIA 1): The number of patients from the denominator admitted with an infection requiring device removal or surgical revision within 180 days following CIED implantation, replacement, or revision Numerator Instructions: INVERSE MEASURE - A lower calculated performance rate for this measure indicates better clinical care or control. The Performance Not Met numerator option for this measure is the representation of the better clinical quality or control. Reporting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control. OR Numerator Options: Performance Met: Performance Not Met: OR Patient admitted within 180 days, status post CIED implantation, replacement, or revision with an infection requiring device removal or surgical revision (G9410) Patient not admitted within 180 days, status post CIED implantation, replacement, or revision with an infection requiring device removal or surgical revision (G9411) REPORTING CRITERIA 2: PATIENTS WITH A REPLACED OR REVISED CIED DENOMINATOR (REPORTING CRITERIA 2): 2 of 11

All patients with replacement or revision of a CIED from January 1, 2017 through June 30, 2017 of the reporting period Definition: CIEDs encompassed for this measure are the following devices: Pacemaker devices (single or dual chamber); Implantable cardioverter-defibrillators (ICDs, single or dual chamber); Cardiac resynchronization devices (pacemaker or ICD); and Implantable loop recorders (ILRs) Denominator Criteria (Eligible Cases) 2: All patients, regardless of age AND Codes for CIED implantation, replacement, or revision (ICD-10-CM, ICD-10-PCS procedure codes): 02H40JZ, 02H40KZ, 02H40MZ, 02H43JZ, 02H43KZ, 02H43MZ, 02H44JZ, 02H44KZ, 02H44MZ, 02H60JZ, 02H60KZ, 02H60MZ, 02H63JZ, 02H63KZ, 02H63MZ, 02H64JZ, 02H64KZ, 02H64MZ, 02H70JZ, 02H70KZ, 02H70MZ, 02H73JZ, 02H73KZ, 02H73MZ, 02H74JZ, 02H74KZ, 02H74MZ, 02HK0JZ, 02HK0KZ, 02HK0MZ, 02HK3JZ, 02HK3KZ, 02HK3MZ, 02HK4JZ, 02HK4KZ, 02HK4MZ, 02HL0JZ, 02HL0KZ, 02HL0MZ, 02HL3JZ, 02HL3KZ, 02HL3MZ, 02HL4JZ, 02HL4KZ, 02HL4MZ, 02HN0JZ, 02HN0KZ, 02HN0MZ, 02HN3JZ, 02HN3KZ, 02HN3MZ, 02HN4JZ, 02HN4KZ, 02HN4MZ, 02PA0MZ, 02PA3MZ, 02PA4MZ, 02PAXMZ, 02WA0MZ, 02WA3MZ, 02WA4MZ, 0JH604Z, 0JH605Z, 0JH606Z, 0JH607Z, 0JH608Z, 0JH609Z, 0JH60PZ, 0JH634Z, 0JH635Z, 0JH636Z, 0JH637Z, 0JH638Z, 0JH639Z, 0JH63PZ, 0JH804Z, 0JH805Z, 0JH806Z, 0JH807Z, 0JH808Z, 0JH809Z, 0JH80PZ, 0JH834Z, 0JH835Z, 0JH836Z, 0JH837Z, 0JH838Z, 0JH839Z, 0JH83PZ, 0JPT0PZ, 0JPT3PZ, 0JWT0PZ, 0JWT3PZ, R50.81, R50.9 AND/OR Patient encounter during performance period (CPT): 33202, 33203, 33206, 33207, 33208, 33212, 33213, 33214, 33215, 33216, 33217, 33218, 33220, 33221, 33222, 33223, 33224, 33225, 33226, 33227, 33228, 33229, 33240, 33249, 33262, 33263, 33264, 33270, 33271, 33272, 33273, 33282, 93260, 93261 AND Replaced or revised CIED AND NOT DENOMINATOR EXCLUSION: Patients undergoing heart transplantation (ICD-10-PCS procedure codes): 02YA0Z2 NUMERATOR (REPORTING CRITERIA 2): The number of patients from the denominator admitted with an infection requiring device removal or surgical revision within 180 days following CIED implantation, replacement, or revision. Numerator Instructions: INVERSE MEASURE - A lower calculated performance rate for this measure indicates better clinical care or control. The Performance Not Met numerator option for this measure is the representation of the better clinical quality or control. Reporting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control. OR Numerator Options: Performance Met: Performance Not Met: Patient admitted within 180 days, status post CIED implantation, replacement, or revision with an infection requiring device removal or surgical revision (G9412) Patient not admitted within 180 days, status post CIED implantation, replacement, or revision with an infection requiring device removal or surgical revision (G9413) 3 of 11

RATIONALE: The rate of implantable cardioverter-defibrillator (ICD) infections has been increasing faster than that of device implantation and is associated with substantial morbidity, mortality, and financial cost. A recent study including over 200,000 ICD implant patients found 2 percent of patients undergoing ICD implantation experienced a device-related infection. Patients who developed an ICD infection were likely to have more comorbidity burden, warfarin use, and coronary sinus lead, device upgrade/malfunction as the last surgery, peri-icd implant complications, and non-ep trained operator. The evidence demonstrates the need to measure performance in this area. CLINICAL RECOMMENDATION STATEMENTS: In recognition that there is an absence of applicable physician-level performance measures for the profession of cardiac electrophysiology, the Heart Rhythm Society (the international professional society focused on the care of patients with heart rhythm disorders) convened a Performance Measures Development Task Force to consider and develop potential physician-level measures for cardiac electrophysiologists. The task force consisted of thought leaders in 1) implantation of cardiac implantable electronic devices (CIEDs) including pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization devices (pacemaker or ICD); and implantable loop recorders (ILRs), 2) cardiovascular health policy, 3) performance measures development, 4) clinical outcomes, and population science. The process for consideration of the evidence included review of the relevant literature referenced within this document and in the knowledge of the members of the task force (Voigt et al, 2006; Cabell et al, 2004; Voigt et al, 2010; Greenspon et al, 2011; Sohail et al, 2011; Nery et al, 2010; Ferguson et al, 1996; Uslan et al, 2007; Lee et al, 2010; Klug et al, 2007; Alter et al, 2005; Al-Khatib et al, 2008; de Oliveira et al, 2009; Uslan et al, 2011; Borleffs et al, 2010; Sohail et al, 2007; Bloom et al, 2006; Baddour et al, 2010; Le KY et al, 2011; Johansen et al, 2011; Al-Khatib et al, 2005; Tarakji et al, 2010). The number of CIED-related infections in the United States continues to increase out of proportion to the increase in the CIED implantation rates (Voigt et al, 2006; Cabell et al, 2004; Voigt et al, 2010). This infection burden is associated with increased mortality, prolonged hospital stays and high financial costs (Greenspon et al, 2011; Sohail et al, 2011; Ferguson et al, 1996). Collectively, the incidence of CIED infection has ranged from 0.3 to 2.9% across the literature evaluated (Greenspon et al, 2011; Sohail et al, 2011; Nery et al, 2010; Uslan et al, 2007; Lee et al, 2010; Klug et al, 2007; Alter et al, 2005; Al-Khatib et al, 2008; Uslan et al, 2011; Bloom et al, 2006; Baddour et al, 2010; Johansen et al, 2011). In the vast majority of patients, CIED infection is preventable, and an association between a higher volume of ICD implants and a lower rate of infections has been demonstrated (Tarakji et al, 2010). This is why a performance measure that could lower the risk of CIED infection is critically needed. COPYRIGHT: Heart Rhythm Society, 2015. All rights reserved. 4 of 11

5 of 11

6 of 11

7 of 11

2017 Registry Individual Measure Flow #393: HRS-9: Infection Within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision Please refer to the specific section of the Measure Specification to identify the denominator and numerator information for use in reporting this Individual Measure. NOTE: A lower calculated performance rate for this measure indicates better clinical care or control. This measure includes 2 Reporting Criteria. REPORTING CRITERIA 1: 1. Start with Denominator 2. Check Patient Procedure and/or Encounter Performed Code: a. If CIED Implantation Procedure and/or Encounter Code as Listed in Denominator equals No, do not include in Eligible population. Stop Processing b. If CIED Implantation Procedure and/or Encounter Code as Listed in Denominator equals Yes, proceed to check New CIED. 3. Check New CIED: a. If New CIED equals No, do not include in Eligible Patient Population. Stop Processing. b. If New CIED equals Yes, proceed to check Patients Undergoing Heart Transplant. 4. Check Patients Undergoing Heart Transplantation a. If Patients Undergoing Heart Transplantation as Listed in the Denominator equals No, include in Eligible Population. b. If Patients Undergoing Heart Transplantation as Listed in the Denominator equals Yes, do not include in Eligible Patient Population. Stop Processing. 5. Denominator Population: a. Denominator population is all Eligible Patients in the denominator. Denominator is represented as Denominator in the Sample Calculation listed at the end of this document. Letter d 1 equals 8 patients in the sample calculation. 6. Start Numerator 7. Check Patient Admitted within 180 days, Status Post CIED Implantation, Replacement, or Revision with an Infection Requiring Device Removal or Surgical Revision: a. If Patient Admitted within 180 days, Status Post CIED Implantation, Replacement, or Revision with an Infection Requiring Device Removal or Surgical Revision equals Yes, include in Data Completeness Met and Performance Met. b. Data Completeness Met and Performance Met is represented in the Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter a 1 equals 4 patients in Sample Calculation. 8 of 11

c. If Patient Admitted within 180 days, Status Post CIED Implantation, Replacement, or Revision with an Infection Requiring Device Removal or Surgical Revision equals No, proceed to check Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision. 8. Check Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision: a. If Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision equals Yes, include in Data Completeness Met and Performance Not Met. b. Data Completeness Met and Performance Not Met is represented in the Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter c 1 equals 3 patients in the Sample Calculation. c. If Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision equals No, proceed to Data Completeness Not Met. 9. Check Data Completeness Not Met: a. If Data Completeness Not Met equals No, Quality Data Code or equivalent was not reported. 1 patient has been subtracted from the data completeness numerator in the sample calculation. 9 of 11

2017 Registry Individual Measure Flow #393: HRS-9: Infection Within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision Please refer to the specific section of the Measure Specification to identify the denominator and numerator information for use in reporting this Individual Measure. NOTE: A lower calculated performance rate for this measure indicates better clinical care or control. This measure includes 2 Reporting Criteria. REPORTING CRITERIA 2: 1. Start with Denominator 2. Check Patient Procedure Code: a. If CIED Implantation Procedure and/or Encounter Code as Listed in Denominator equals No, do not include in Eligible population. Stop Processing. b. If CIED Implantation Procedure and/or Encounter Code as Listed in Denominator equals Yes, proceed to check Replacement or Revision of CIED. 3. Check Replacement or Revision of CIED: a. If Replacement or Revision of CIED equals No, do not include in Eligible Patient Population. Stop Processing. b. If Replacement or Revision of CIED equals Yes, proceed to check Patients Undergoing Heart Transplantation. 4. Check Patients Undergoing Heart Transplantation a. If Patients Undergoing Heart Transplantation as Listed in the Denominator equals No, include in Eligible Population. b. If Patients Undergoing Heart Transplantation as Listed in the Denominator equals Yes, do not include in Eligible Patient Population. Stop Processing. 5. Denominator Population: a. Denominator population is all Eligible Patients in the denominator. Denominator is represented as Denominator in the Sample Calculation listed at the end of this document. Letter d 2 equals 8 patients in the sample calculation. 6. Start Numerator 7. Check Patient Admitted within 180 days, Status Post CIED Implantation, Replacement, or Revision with an Infection Requiring Device Removal or Surgical Revision: a. If Patient Admitted within 180 days, Status Post CIED Implantation, Replacement, or Revision with an Infection Requiring Device Removal or Surgical Revision equals Yes, include in Data Completeness Met and Performance Met. 10 of 11

b. Data Completeness Met and Performance Met is represented in the Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter a 2 equals 4 patients in Sample Calculation. c. If Patient Admitted within 180 days, Status Post CIED Implantation, Replacement, or Revision with an Infection Requiring Device Removal or Surgical Revision equals No, proceed to check Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision. 8. Check Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision: a. If Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision equals Yes, include in Data Completeness Met and Performance Not Met. b. Data Completeness Met and Performance Not Met is represented in the Data Completeness and Performance Rate in the Sample Calculation listed at the end of this document. Letter c 2 equals 3 patients in the Sample Calculation. c. If Patient Not Admitted within 180 days, Status Post CIED Implantation, Replacement, Revision with an Infection Requiring Device Removal or Surgical Revision equals No, proceed to Data Completeness Not Met. 9. Check Data Completeness Not Met: a. If Data Completeness Not Met equals No, Quality Data Code or equivalent was not reported. 1 patient hs been subtracted from the data completeness numerator in the Sample Calculation. 11 of 11